Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

CTRE vs XRN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CTRE Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 10–0 Matrix Metrics)

CTRE Overall Winner 6-Pillar Tally: CTRE 6 – 0 XRN Matrix Metrics: CTRE 10 – 0 XRN

As of Nov 17, 2026, CareTrust REIT, Inc (CTRE) is the stronger overall head-to-head candidate over XRN (XRN) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CTRE carries a Unified Composite Score of 56.4/100 (HOLD) at $37.23 (19.7x Forward P/E, 66.2% operating margin), whereas XRN carries 45.3/100 (HOLD) at $25.79 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: CTRE is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 48.9); meanwhile XRN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CTRE vs XRN
CTRE NYSE Head-to-Head Winner
CareTrust REIT, Inc
Real Estate Investment Trusts
$37.23
-0.43% 1D
Market Cap $9.8B
TTM Revenue $615M
Forward P/E 19.7x
Beta / 30D Vol 0.16β · 28% Vol
Unified Composite Score
56.4 / 100 HOLD
Tech 47.0 Fund 54.0 Flow 57.0 Mom 60.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -2.3%) with fading momentum, RSI 49
RSI-14: 48.9 · SMA20: $37.17 · SMA50: $37.12
XRN US Equity
XRN
Institutional Equity
$25.79
-2.35% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.50β · 47% Vol
Unified Composite Score
45.3 / 100 HOLD
Tech 45.0 Fund 53.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.1%), weak momentum, RSI 28
RSI-14: 28.5 · SMA20: $28.74 · SMA50: $32.14

6-Pillar Scorecard Institutional Category Breakdown (CTRE 6 – 0 XRN)

Columns: Metric · CTRE · XRN
1. Valuation Multiples CTRE
Forward P/E 19.7x N/M
Trailing P/E 23.9x N/M
PEG Ratio 1.26x N/M
EV / Revenue 18.5x N/M
2. Growth & Scale CTRE
Revenue Growth (YoY) +33.2% N/A
Earnings Growth (YoY) -0.8% N/A
TTM Revenue (USD) $615M N/A
Market Cap $9.8B N/A
3. Profitability & Quality CTRE
Gross Margin 95.7% N/A
Operating Margin 66.2% N/A
Net Profit Margin 59.2% N/A
Return on Equity (ROE) 7.7% N/A
4. Balance Sheet & Cash Flow CTRE
Cash Generation (TTM) $485M N/A
Cash Flow Margin 78.8% N/A
Net Cash / Leverage $1.59B Net Debt (0.39x D/E) N/A ROE
Dividend Yield 3.94% None (0.00%)
5. Options & Positioning CTRE
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 25.1% (11th %ile) N/A (N/A)
Put/Call OI Skew 6.00x (Put-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Distribution NEUTRAL · Markdown
6. R&D & Supply-Chain Moat CTRE
OpEx & R&D Intensity 29.5% of Rev ($182M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role REIT - Healthcare Facilities Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CTRE (10) vs XRN (0)
Institutional Metric CTRE XRN Criterion Row Edge
Market Capitalization
Scale
$9.8B N/A Larger Scale CTRE
Trailing P/E Ratio
Valuation
23.9x N/M Lower Multiple CTRE
Forward P/E Ratio
Valuation
19.7x N/M Lower Multiple CTRE
Revenue Growth (YoY)
Growth
+33.2% N/A Higher Growth CTRE
Operating Margin (TTM)
Profitability
66.2% N/A Higher Margin CTRE
Net Profit Margin
Profitability
59.2% N/A Higher Margin CTRE
Return on Equity (ROE)
Capital Efficiency
7.7% N/A Higher ROE CTRE
52-Week Range Position
Momentum
28% ($35–$44) 1% ($26–$39) Stronger Trend CTRE
Beta / 30D Volatility
Risk Regime
0.16β · 28% Vol 0.50β · 47% Vol Lower Realized Risk CTRE
Unified Institutional Score
Composite Signal
56.4 / 100 (HOLD) 45.3 / 100 (HOLD) Higher Composite CTRE
Trailing 12M Revenue (USD)
Operating Scale
$615M N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
95.7% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.26x PEG · 18.5x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$485M ($1.59B Net Debt (0.39x D/E)) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CTRE +16.9 pp
CTRE: +3.88% · XRN: -13.02%
3M Horizon CTRE +23.55 pp
CTRE: -6.5% · XRN: -30.05%
6M Horizon CTRE +15.15 pp
CTRE: -9.75% · XRN: -24.9%
1Y Horizon CTRE +20.09 pp
CTRE: -8.07% · XRN: -28.16%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CTRE vs XRN. Trailing 12-month operating profitability (CTRE 66.2% vs XRN N/A) and valuation multiples (CTRE 19.7x vs XRN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

CTRE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$615M
Gross Margin95.7%
Op. Margin66.2%
ROE / Fwd P/E7.7% · 19.7x
XRN ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CTRE CONSOLIDATION
84d in phase · OBV DISTRIBUTION
Current IV 25.1%
IV Percentile 11th %ile
Put/Call OI Skew 6.00x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact CTRE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
XRN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact XRN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $37.39 · IV 27.6%

CTRE Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($3,739)

Compare $3,739 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 27.6% ATM IV.

5-DAY BULLISH SWING Liq C

Dec 18 $37.5 / $40 Bull Call Spread

Buy 1x $37.5C · Sell 1x $40C · 32d

Net Entry $88 Debit
T+5d @ +5% Move +$62 (+70%)
Max Risk / Buffer $88 Capped
5d Edge & Liquidity 1.0x R:R · Liq C
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq C

Jan 15 '27 $35 / $32.5 Bull Put Spread

Sell 3x $35P · Buy 3x $32.5P · 60d

Net Entry $60 Credit
Max Credit / Yield +$60 (+8.7% RoM)
Max Risk / Buffer -6.9% Cushion ($690 Mgn)
5d Edge & Liquidity 77% PoP · Liq C
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CTRE Moat Profile High-Margin Pricing Power Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $9.8B market capitalization and 66.2% operating margin.
OpEx & R&D Reinvestment 29.5% of Rev ($182M)
90D Engineering Disclosures 0 Published
XRN Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ CTRE vs XRN Key Questions & Quantitative Answers

As of Nov 17, 2026, CareTrust REIT, Inc (CTRE) is the stronger overall head-to-head candidate over XRN (XRN) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CTRE carries a Unified Composite Score of 56.4/100 (HOLD) at $37.23 (19.7x Forward P/E, 66.2% operating margin), whereas XRN carries 45.3/100 (HOLD) at $25.79 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: CTRE is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 48.9); meanwhile XRN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CTRE leads the Growth & Scale pillar: CTRE posts +33.2% YoY revenue growth and -0.8% YoY earnings growth on $615M TTM revenue (95.7% gross margin, 66.2% operating margin), compared with XRN at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, CTRE generates $615M in USD-normalized revenue versus N/A for XRN. In operating R&D and SG&A reinvestment, CTRE deploys 29.5% of Rev ($182M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for XRN.

CTRE screens cheaper on headline valuation multiples. CTRE trades at 19.7x Forward P/E, 23.9x Trailing P/E, 1.26x PEG, and 18.5x EV/Revenue (78.8% FCF margin), whereas XRN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CTRE (7.7% ROE) versus XRN (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, CTRE carries 25.1% implied volatility (11th %ile, Compressed (<25th %ile)), a 6.00x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.16β · 28% Vol realized risk). By comparison, XRN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.50β · 47% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.